ARCHIVES

ORI takes Over Misconduct Inquiry Of NSABP Officials

This article is from The Cancer Letter archive.

Vol. 20 No. 30 | July 29, 1994

Download PDF Visit The Full Archive

Related Articles

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

Zerhouni to Cancer Researchers: “Stay Calm, Cool” About Funding- And Beware of Myths.

June 16, 2006

In Brief: Richard Fisher Named Physician-in-Chief, Executive Vice President at Fox Chase Cancer Center

December 7, 2012

EORTC Screening, Pharmacology Group Focuses On CNU

January 2, 1987

House May Add $80 Million To NCI Budget For FY 1984

September 16, 1983